{"": [83, 1282, 0, 1283, 1835, 0], "Generation and Immunogenicity of Ad26 Vaccine Candidates": [1836, 6001, 0], "Protective Efficacy of Ad26 Vaccine Candidates": [6002, 8054, 0], "Immune Correlates of Protection": [8055, 10073, 0], "Immune Responses in Vaccinated Animals Following Challenge": [10074, 11300, 0], "Discussion": [11301, 15869, 0], "Animals and study design.": [15879, 16990, 0], "Ad26 vectors.": [16991, 17433, 0], "Western blot.": [17434, 18742, 0], "Subgenomic mRNA assay.": [18743, 19738, 0], "Plaque-forming unit (PFU) assay.": [19739, 20488, 0], "Enzyme-linked immunosorbent assay (ELISA).": [20489, 21733, 0], "Pseudovirus neutralization assay.": [21734, 22989, 0], "Live virus neutralization assay.": [22990, 25084, 0], "Luminex.": [25104, 26921, 0], "Antibody-dependent neutrophil phagocytosis (ADNP), antibody-dependent cellular phagocytosis (ADCP), antibody-dependent complement deposition (ADCD).": [26922, 29064, 0], "Antibody-dependent NK cell activation (ADNKA).": [29065, 30330, 0], "Analysis.": [30331, 31568, 0], "Systems serology.": [25085, 31568, 1], "IFN-\u03b3 enzyme-linked immunospot (ELISPOT) assay.": [31569, 33019, 0], "IL-4 ELISPOT assay.": [33020, 33257, 0], "Intracellular cytokine staining (ICS) assay.": [33258, 35058, 0], "Immunophenotyping of BAL cells.": [35059, 36374, 0], "Statistical analyses.": [36375, 36716, 0], "Methods": [15870, 36716, 1], "Extended Data": [36717, 36731, 0], "Supplementary Material": [36732, 36758, 0]}